Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis. - Wikidata - wikimedia - TriplyDB

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

http://www.wikidata.org/entity/Q34942166

about

FGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complex Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases Matrix Metalloproteinases in Non-Neoplastic Disorders.Drugs derived from phage display: from candidate identification to clinical practice Moving targets: Emerging roles for MMPs in cancer progression and metastasis Quantitative FRET imaging to visualize the invasiveness of live breast cancer cells Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas Hedgehog Pathway Antagonist 5E1 Binds Hedgehog at the Pseudo-active Site A Reverse Binding Motif That Contributes to Specific Protease Inhibition by Antibodies Antibodies targeting the catalytic zinc complex of activated matrix metalloproteinases show therapeutic potential MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin Transducer of Cdc42-dependent actin assembly promotes breast cancer invasion and metastasis.Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.Membrane-associated matrix proteolysis and heart failure.Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: contrasting, overlapping and compensatory functions.Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?Endoglin in liver fibrogenesis: Bridging basic science and clinical practice Directed evolution of protease beacons that enable sensitive detection of endogenous MT1-MMP activity in tumor cell lines.Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.Shedding of RANKL by tumor-associated MT1-MMP activates Src-dependent prostate cancer cell migration.Metalloproteinase binding proteins: WO2009097397.Rho-ROCK-myosin signaling mediates membrane type 1 matrix metalloproteinase-induced cellular aggregation of keratinocytes.Matrix metalloproteinases in tumorigenesis: an evolving paradigm.Emerging principles in protease-based drug discovery.PEGylation extends circulation half-life while preserving in vitro and in vivo activity of tissue inhibitor of metalloproteinases-1 (TIMP-1)Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury Matrix metalloproteinases: protective roles in cancer.Specific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits.Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis New strategies for targeting matrix metalloproteinases Phosphoramidate-based peptidomimetic inhibitors of membrane type-1 matrix metalloproteinase Targeting invadopodia to block breast cancer metastasis Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC Contribution of epithelial-to-mesenchymal transition and cancer stem cells to pancreatic cancer progression Targeting Matrix Metalloproteinases in Cancer: Bringing New Life to Old Ideas Matrix metalloproteinases as breast cancer drivers and therapeutic targets.

P2860

Q24297701-BFE9DDEE-CB5A-41A2-817C-34FB42D29E5B Q24617675-E326E9F0-C2DC-4FA2-9599-948FA401510C Q26741827-2DB6C4FE-8AB0-4FE4-8B80-38FA0113F0C2 Q27007101-024B1F4D-B4F8-4CC9-A56E-D04E48FA4885 Q27008735-32FC5AC3-B7A0-4904-93FA-DCA17BB9DE33 Q27334885-2B4AA5AD-12C8-49E1-B176-BC62A5881576 Q27335251-14C47DDF-E6E7-449B-8A8C-2003F245700F Q27661941-1E656D21-048D-431F-99DF-85226E303B76 Q27676066-0F4F3504-8F6E-4E85-986E-36C1E491EC7E Q27676429-5994F1DF-EE42-4F9F-8BAF-9E2607637DB5 Q28480929-6855ADCF-8C5B-455C-82C3-7C6D46E20063 Q30010045-7293C4AC-B8DC-402E-AAB3-E48318D93957 Q30399006-D4B75FC3-B2BC-4274-ACEE-302A5A1ABB0E Q33618445-982D2302-6233-430C-8763-C1BB9A8C58A7 Q33632033-E4510861-972B-45C5-8DB2-9A6143100AB9 Q33665623-6CD0BF23-5B64-4C12-B437-FCB308EEECE3 Q33691403-35E79BC5-9E50-430C-B47C-886DBCFCD430 Q33728841-3C2D8C83-03EC-40F0-BF14-A6DB83C1B14F Q33856620-A8FED672-D9E0-473D-9D4C-B27DF25EECBF Q33915005-8DC5B0C1-17BB-4DC9-82B8-DCB14A22943A Q33958982-FC0B7709-2BB0-48F4-9DE3-D5F7C66B4E8E Q34030049-48F0A550-F042-497E-A424-51D06BB2F3FD Q34107508-201FADAD-50D4-4454-AD9C-CC19C1142549 Q34199345-75828A87-7412-469C-B1F5-E7410C6DFBBE Q34282102-D180431D-25EC-49E4-A448-C9DFFC9EEC70 Q34490917-22419AA9-E9E8-455C-AE12-C115D12B71D0 Q34971595-013A9ABE-52B0-4C51-BF06-016D91C129C8 Q35055608-3FD6CCEF-EC49-41F0-99B5-F99578DC0D7D Q35216059-AA4F1E65-4007-4504-8FC9-D9FAEC3319EA Q35261656-E9DCDAC0-CA33-4C92-BB1D-AD47EB5F36CA Q35313033-5655FA63-1BB0-4F6E-B228-2E73B979AA43 Q35474102-5C3E13D5-43F0-4F7E-B446-E56D0DD03725 Q35525477-8F9AE5BB-D4A5-47D2-8142-1C573A5E2BE7 Q35544060-111F7EF7-54E5-4376-AAAF-7D3C718C8944 Q35588436-C19EC1CB-CACE-4C4B-9A78-6D06CBF51366 Q35640216-3500C3F6-73EC-4828-B5FB-B010F5B262B7 Q35654027-E77592FA-BF6B-41AD-8FBE-78B22A94C4EE Q35754181-E24234F8-7BA9-4AF3-9999-53F8B5192F8D Q35760031-3B09D2A1-9378-4AC5-B108-3EACDAF7D1D2 Q35892721-0C0291D2-7CEF-4AC8-AB39-4AA4932FC69A

P2860

Selective inhibition of matrix metalloproteinase-14 blocks tumor growth, invasion, and angiogenesis.

http://www.wikidata.org/entity/Q34942166

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@ast

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@en

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@nl

type

label

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@ast

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@en

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@nl

prefLabel

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@ast

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@en

Selective inhibition of matrix ...... h, invasion, and angiogenesis.

@nl

P1433

Q34942166-92E80272-A107-412F-90F5-02088F33A9F8

P1476

Q34942166-8CA59EF3-AC35-4307-AA67-B6B3464B2A1C

P2093

Q34942166-0F0BD8F0-A27A-4E34-AAC5-7EE5C2C6D5F2

Q34942166-1AC20862-1DDA-45C6-9298-88E50F330C7C

Q34942166-1E3A3A03-F721-4135-AF26-A9BCBA6A5472

Q34942166-2B1E1511-7BD9-4682-B029-2324A9A5372B

Q34942166-4BCE8AFC-3BB4-4CB9-810C-6E280E3F5979

Q34942166-54ABD44A-DAA2-4C54-9037-65635E18ECD8

Q34942166-552370C7-D541-4913-83A4-2783F5127E2A

Q34942166-672A29B8-6A1F-4429-A7EA-04E6059AD893

Q34942166-74A6C9FF-2BD2-4337-8661-DA5390A54573

Q34942166-754677DE-4B7C-4970-9079-4EACD09FA4E1

P304

Q34942166-013B0FAA-AECE-4A0B-AB82-2498B2AD5931

P31

Q34942166-5558A5E3-7C9A-4866-AD49-E83C4E4DEB65

P356

Q34942166-70DE1089-6E80-4F25-8BBA-595DCD92B946

P407

Q34942166-2C16DF41-4A23-469C-9548-E45127E5A0FD

P433

Q34942166-6DD9E151-462E-4101-8DC8-71574D0297B3

P478

Q34942166-83865849-E7D1-4E82-9F26-F80514D9AD66

P50

Q34942166-0189AB17-DA54-4059-B6DF-1B3AD8A161F9

Q34942166-3551BCA7-B703-476D-8D70-0434B0F0CE70

P577

Q34942166-2144DF4F-8B3D-45FA-9074-9F4A7A839E2E

P5875

Q34942166-7AD8BCB8-DD87-4E1D-9067-EF30B36851A8

P698

Q34942166-CA689BA5-221A-440C-8B77-E63E0CB3B5D0

P356

0008-5472.CAN-08-3255

P1433

Cancer Research

P1476

Selective inhibition of matrix ...... th, invasion, and angiogenesis

@en

P2093

Andrew E Nixon

http://www.w3.org/2001/XMLSchema#string

Annabelle Lejeune

http://www.w3.org/2001/XMLSchema#string

Chris Tenhoor

http://www.w3.org/2001/XMLSchema#string

Clive R Wood

http://www.w3.org/2001/XMLSchema#string

Csaba Pazmany

http://www.w3.org/2001/XMLSchema#string

Daniel T Dransfield

http://www.w3.org/2001/XMLSchema#string

Douglas Rank

http://www.w3.org/2001/XMLSchema#string

Edward Chang

http://www.w3.org/2001/XMLSchema#string

Guannan Kuang

http://www.w3.org/2001/XMLSchema#string

Henk Pieters

http://www.w3.org/2001/XMLSchema#string

P304

1517-1526

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-08-3255

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

Daniel J Sexton

P577

2009-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23999250

http://www.w3.org/2001/XMLSchema#string

P698

19208838

http://www.w3.org/2001/XMLSchema#string